↓ Skip to main content

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Overview of attention for article published in JAMA Ophthalmology, October 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
3 news outlets
twitter
25 X users
patent
1 patent
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
309 Dimensions

Readers on

mendeley
310 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Published in
JAMA Ophthalmology, October 2018
DOI 10.1001/jamaophthalmol.2018.3255
Pubmed ID
Authors

Jeffrey G. Gross, Adam R. Glassman, Danni Liu, Jennifer K. Sun, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, Michael J. Elman, Frederick L. Ferris, Thomas W. Gardner, Lee M. Jampol, Daniel F. Martin, Michele Melia, Cynthia R. Stockdale, Roy W. Beck

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 310 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 310 100%

Demographic breakdown

Readers by professional status Count As %
Other 34 11%
Researcher 29 9%
Student > Ph. D. Student 25 8%
Student > Bachelor 24 8%
Student > Doctoral Student 21 7%
Other 62 20%
Unknown 115 37%
Readers by discipline Count As %
Medicine and Dentistry 121 39%
Biochemistry, Genetics and Molecular Biology 14 5%
Nursing and Health Professions 9 3%
Agricultural and Biological Sciences 7 2%
Unspecified 6 2%
Other 33 11%
Unknown 120 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2024.
All research outputs
#1,045,540
of 26,813,756 outputs
Outputs from JAMA Ophthalmology
#535
of 6,874 outputs
Outputs of similar age
#21,211
of 358,502 outputs
Outputs of similar age from JAMA Ophthalmology
#14
of 97 outputs
Altmetric has tracked 26,813,756 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,874 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,502 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.